hotspotthera.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $380.54MM
Hotspot Therapeutics derives medical solutions from natural solutions.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/29/2021 | Series C | $100.14MM | $xx.xx | $300.77MM | Atlas Venture, B Capital Group, Caas Capital Management, Lsp, Monashee Investment Management, Mrl Ventures Fund, Pavilion Capital, Pivotal Bioventure Partners, Revelation Partners, Sofinnova Partners, Sr One Capital Management, Tekla Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
30,899,006
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atlas Venture, B Capital Group, Caas Capital Management, Lsp, Monashee Investment Management, Mrl Ventures Fund, Pavilion Capital, Pivotal Bioventure Partners, Revelation Partners, Sofinnova Partners, Sr One Capital Management, Tekla Capital Management
|
||||||
05/21/2020 | Series B | $65.13MM | $xx.xx | $134.84MM | Atlas Venture, Brace Pharma, Mrl Ventures Fund, Sofinnova Partners, Solasta Ventures, S.R. One, Tekla Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
27,138,012
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atlas Venture, Brace Pharma, Mrl Ventures Fund, Sofinnova Partners, Solasta Ventures, S.R. One, Tekla Capital Management
|
||||||
07/17/2018 | Series A | $20MM | $xx.xx | $40MM | Atlas Venture, Sofinnova Partners | |
Price per Share
$xx.xx
Shares Outstanding
10,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atlas Venture, Sofinnova Partners
|
||||||
01/05/2017 | Series Seed | $5MM | $xx.xx | $12.5MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|